These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Infectivity of blood seropositive for hepatitis C virus antibodies. van der Poel CL; Reesink HW; Schaasberg W; Leentvaar-Kuypers A; Bakker E; Exel-Oehlers PJ; Lelie PN Lancet; 1990 Mar; 335(8689):558-60. PubMed ID: 1968574 [TBL] [Abstract][Full Text] [Related]
7. Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B, hepatitis. Hoyos M; Sarrión JV; Pérez-Castellanos T; Prieto M; Marty ML; Garrigues V; Berenguer J Hepatology; 1989 Mar; 9(3):449-51. PubMed ID: 2493415 [TBL] [Abstract][Full Text] [Related]
8. [Public Health Council advisory: prevention of post-transfusion non-A non-B hepatitis; is application of a surrogate test a missed station?]. Brandt KH Ned Tijdschr Geneeskd; 1989 Nov; 133(45):2212-4. PubMed ID: 2509949 [No Abstract] [Full Text] [Related]
9. [Transfusion safety]. Aprili G Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537 [No Abstract] [Full Text] [Related]
12. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Garson JA; Tedder RS; Briggs M; Tuke P; Glazebrook JA; Trute A; Parker D; Barbara JA; Contreras M; Aloysius S Lancet; 1990 Jun; 335(8703):1419-22. PubMed ID: 1972209 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenetic chronic liver disease. Sansonno D; Dammacco F Lancet; 1989 Sep; 2(8666):798-9. PubMed ID: 2571030 [No Abstract] [Full Text] [Related]
14. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis. Takano S; Omata M; Ohto M; Nakamura K Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514 [TBL] [Abstract][Full Text] [Related]
16. Surrogate testing for non-A, non-B hepatitis. Anderson CC; Contreras M; Barbara JA; Mijovic V Lancet; 1987 Apr; 1(8538):912. PubMed ID: 2882303 [No Abstract] [Full Text] [Related]
17. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg. Chung HT; Lee JS; Lok AS Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569 [TBL] [Abstract][Full Text] [Related]
18. [Donors blood screening and prevention of posttransfusion type C hepatitis in Japan]. Yoshizawa H Uirusu; 1993 Dec; 43(2):315-21. PubMed ID: 7510090 [No Abstract] [Full Text] [Related]
19. Hepatitis C virus infection and liver transplantation. Grendele M; Gridelli B; Colledan M; Rossi G; Rainero Fassati L; Ferla G; Lunghi G; Galmarini D Lancet; 1989 Nov; 2(8673):1221-2. PubMed ID: 2572934 [No Abstract] [Full Text] [Related]